Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,97 USD | -0,44% | +0,11% | -20,20% |
Vakgebied
Aantal werknemers: 99
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Human Therapeutics
100,0
%
| 51 | 100,0 % | 57 | 100,0 % | +11,84% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
99,6
%
| 51 | 99,6 % | 57 | 99,6 % | +11,89% |
Europe
0,4
%
| 0 | 0,4 % | 0 | 0,4 % | +0,45% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 01-07-13 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 01-06-14 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-14 |
Richard Graham
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rhonda Farnum
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-07-18 |
Aine Miller
PRN | Corporate Officer/Principal | - | - |
Stacy Pryce
PRN | Corporate Officer/Principal | - | - |
Brett Grimaud
LAW | General Counsel | 50 | 01-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 01-06-14 |
Eran Broshy
BRD | Director/Board Member | 65 | 02-06-14 |
Burt Malkiel
BRD | Director/Board Member | 90 | 01-10-13 |
Director/Board Member | 59 | 01-07-20 | |
Susannah Gray
BRD | Director/Board Member | 63 | 26-02-23 |
Rick Winningham
CEO | Chief Executive Officer | 64 | 01-07-13 |
Jim Kelly
BRD | Director/Board Member | 43 | 11-04-23 |
Donal O'Connor
BRD | Director/Board Member | 73 | 21-10-15 |
Laurie Alsup
BRD | Director/Board Member | 70 | 13-02-18 |
Director/Board Member | - | 21/12 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 48 164 708 | 45 678 650 ( 94,84 %) | 0 | 94,84 % |
Bedrijfsgegevens
Theravance Biopharma, Inc.
901 Gateway Boulevard
94080, South San
+650 808 6000
http://www.theravance.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,20% | 434 mln. | |
+33,46% | 701 mld. | |
+26,24% | 571 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,61% | 157 mld. |
- Beurs
- Aandelen
- Aandeel Theravance Biopharma, Inc. - Nasdaq
- Onderneming Theravance Biopharma, Inc.